MONOACYLGLYCEROLS FOR USE IN THE TREATMENT OF MALABSORPTION HAVING A MECHANICAL BASIS
    12.
    发明公开
    MONOACYLGLYCEROLS FOR USE IN THE TREATMENT OF MALABSORPTION HAVING A MECHANICAL BASIS 审中-公开
    甘油一酯用于与机构基座吸收问题的处理

    公开(公告)号:EP3062786A1

    公开(公告)日:2016-09-07

    申请号:EP14795980.3

    申请日:2014-10-27

    申请人: Nestec S.A.

    IPC分类号: A61K31/232 A61P3/02

    CPC分类号: A61K31/232

    摘要: Compositions comprising monoacylglycerols (MAG), such as sn-1(3) MAG, are administered to an individual having or at risk of malabsorption having a mechanical basis, such as malabsorption associated with a biliary fistula, a biliary obstruction, or short bowel syndrome from bowel surgery (resection) or bariatric surgery. Preferably the compositions are administered concurrently with fat-soluble nutrients. The compositions and the methods of using the compositions enhance absorption of fatty acids and fat-soluble nutrients, such as fat-soluble vitamins and carotenoids, to address nutritional deficiencies due to malabsorption having a mechanical basis, such as malabsorption associated with a biliary fistula, a biliary obstruction, or short bowel syndrome from bowel surgery (resection) or bariatric surgery.

    NUTRITIONAL COMPOSITIONS COMPRISING SN-1 (3) MONOACYLGLYCEROLS FOR USE IN THE TREATMENT OF MALABSORPTION OR MALDIGESTION IN INFANTS OR YOUNG CHILDREN
    14.
    发明公开
    NUTRITIONAL COMPOSITIONS COMPRISING SN-1 (3) MONOACYLGLYCEROLS FOR USE IN THE TREATMENT OF MALABSORPTION OR MALDIGESTION IN INFANTS OR YOUNG CHILDREN 审中-公开
    包含SN-1(3)单乙酰甘油的营养组合物用于治疗婴儿或幼儿中的吸入性疾病或马化产物

    公开(公告)号:EP3212181A1

    公开(公告)日:2017-09-06

    申请号:EP15781655.4

    申请日:2015-10-19

    申请人: Nestec S.A.

    摘要: The present invention refers to nutritional composition comprising sn-1(3) monoacylglycerols for use in the treatment or prevention of maldigestion and/or malabsorption in an infant or young child. It also refers to a nutritional composition comprising sn-1(3) monoacylglycerols for use to increase lipid (e.g. fatty acids) absorption/delivery and/or to increase the energy or the mineral bioavailability in an infant or young child. The infant or young child may have a gut immaturity and/or a reduced enteral feeding tolerance. They may also be pretermand/or low birth weight.

    摘要翻译: 本发明涉及包含sn-1(3)单酰基甘油的营养组合物,用于治疗或预防婴儿或幼儿的消化不良和/或吸收不良。其还涉及包含sn-1(3)单酰基甘油 用于增加婴儿或幼儿的脂质(例如脂肪酸)吸收/递送和/或增加能量或矿物质生物利用度。婴幼儿可能具有肠道不成熟和/或肠内喂养耐受性降低。 他们也可能是pretermand /或低出生体重。

    MONOACYLGLYCEROLS FOR USE IN CONJUNCTION WITH A LIPASE INHIBITOR AND/OR DIETS LOW IN FAT AND/OR CALORIES
    17.
    发明公开
    MONOACYLGLYCEROLS FOR USE IN CONJUNCTION WITH A LIPASE INHIBITOR AND/OR DIETS LOW IN FAT AND/OR CALORIES 审中-公开
    用于与脂肪酶抑制剂连接甘油一酯和/或脂肪或低热量饮食

    公开(公告)号:EP3062787A1

    公开(公告)日:2016-09-07

    申请号:EP14795981.1

    申请日:2014-10-27

    申请人: Nestec S.A.

    摘要: In an embodiment, compositions comprising monoacylglycerols (MAG), such as sn-1(3) MAG, are administered with a lipase inhibitor, such as tetrahydrolipstatin, and/or with a diet low in fat and/or calories. In another embodiment, compositions comprising MAG, such as sn-1(3) MAG, are administered concurrently with a lipase inhibitor, such as tetrahydrolipstatin, and/or with fat-soluble nutrients. The compositions and the methods of using the compositions enhance absorption of fatty acids and fat-soluble nutrients such as fat-soluble vitamins and carotenoids to address nutritional deficiencies due to a weight loss diet used in association with a lipase inhibitor.

    摘要翻译: ,实施例组合物,包含单酰基甘油(MAG)在,:如Sn-1(3)MAG,施用,所述脂肪酶抑制剂,如四氢里卜斯他丁检查,和/或与在脂肪和/或卡路里饮食低。 在另一个实施方式组合物,包含MAG,作为检查的sn-1(3)MAG,与脂肪酶抑制剂同时施用如四氢检查,和/或与脂溶性营养物。 的组合物和使用该组合物的方法中提高的脂肪酸和脂溶性营养物吸收:按照脂溶性维生素和类胡萝卜素,以解决营养缺乏这样由于在关联使用脂酶抑制剂的重量损失的饮食。